QVance AB publishes particulates article in collaboration with ISCT
QVance AB, Huddinge, Sweden has today announced its co-founder and CSO at parent company, NextCell Pharma AB, Dr Lindsay Davies, has published an article in the journal Cytotherapy. Dr Davies is a member of the International Society of Cell and Gene Therapy (ISCT) where she is the European Regional Secretary and a member of the Manufacturing Materials Safety and Technology Working Group (MMST).The article, entitled “Particulates in CGT Guidance Survey Results - Cell and Gene Therapy Industry Knowledge Awareness”, is the result of the MMST´s extensive work to globally survey cell and gene
